(Q28326502)

https://api.crossref.org/works/10.1016/0091-3057(91)90032-W

4 December 2022

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90032-W

4 December 2022

K. A. Trujillo

1

1 reference

Europe PubMed Central

PubMed ID

1829839

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1829839

4 December 2022

H. Akil

2

1 reference

Europe PubMed Central

PubMed ID

1829839

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1829839

full work available at URL

4 December 2022

language of work or name

English

0 references

publication date

March 1991

0 references

https://api.elsevier.com/content/article/PII:009130579190032W?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90032-W

https://api.elsevier.com/content/article/PII:009130579190032W?httpAccept=text/plain

4 December 2022

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90032-W

Pharmacology, Biochemistry and Behavior

4 December 2022

published in

0 references

volume

38

0 references

issue

3

0 references

page(s)

673-5

0 references

cites work

Synthetic opioids compared with morphine and ketamine: catalepsy, cross-tolerance and interactions in the rat.

1

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90032-W

Toxicity of phencyclidine and ethanol in combination

4 December 2022

2

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90032-W

Enhancement of opioid cataleptic response by cortical frontal deafferentation or intrastriatal injection of NMDA-receptor antagonists

4 December 2022

3

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90032-W

The noncompetitive N-methyl-D-aspartate antagonists, MK-801, phencyclidine and ketamine, increase the potency of general anesthetics.

4 December 2022

5

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90032-W

Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine

4 December 2022

6

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90032-W

Excitatory amino acids and the basal ganglia: implications for the therapy of Parkinson's disease

4 December 2022

8

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90032-W

Effects of NMDA antagonists, MK-801 and CPP, upon local cerebral glucose use

4 December 2022

9

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90032-W

Regional neuroprotective effects of the NMDA receptor antagonist MK-801 (dizocilpine) in hypoglycemic brain damage.

4 December 2022

11

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90032-W

Anticataleptic effects of the N-methyl-D-aspartate antagonist MK-801 in rats

4 December 2022

13

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90032-W

The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor.

4 December 2022

14

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90032-W

Inhibition of Morphine Tolerance and Dependence by the NMDA Receptor Antagonist MK-801

4 December 2022

15

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90032-W

Interactions between phencyclidine and central nervous system depressants evaluated in mice and rats.

4 December 2022

17

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90032-W

Immediate and long-lasting effects of MK-801 on motor activity, spatial navigation in a swimming pool and EEG in the rat.

4 December 2022

18

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90032-W

4 December 2022

Identifiers

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

4681307

OpenCitations bibliographic resource ID

4681307

1 reference